N/A
N=17
Dietetic Efficacy of Mare's Milk for Patients With Chronic Inflammatory Bowel Diseases
Ulcerative Colitis · Crohns Disease
Bottom Line
View on ClinicalTrials.gov: NCT00940576 ↗Enrolled (actual)
17
Serious AEs
0.0%
Results posted
Apr 2015
Primary outcome: Primary: Score of Crohn´s Disease and/or Ulcerative Colitis — 58; 1.8; 43; 1.2 units on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- mare´s milk (Dietary_supplement); placebo drink (Other)
- Age
- Pediatric, Adult · 10+ yrs
- Sex
- All
- Sponsor
- University of Jena
- Primary completion
- Feb 2001
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Score of Crohn´s Disease and/or Ulcerative Colitis |
58; 1.8; 43; 1.2; 51; 1.8 | — |
| SECONDARY Extra-intestinal Pain |
28; 37; 29; 29; 10 | — |
Summary
Mare's milk consumption could improve the well-being in patients with Crohn's disease and ulcerative colitis, respectively.
Eligibility Criteria
Inclusion Criteria
clear and definite diagnosis of ulcerative colitis and Crohn's disease resp.
Exclusion Criteria
lactose intolerance and pregnancy
Data sourced from ClinicalTrials.gov (NCT00940576). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.